HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency.

AbstractBACKGROUND:
Primary coenzyme Q(10) (CoQ(10)) deficiency is rare. The encephalomyopathic form, described in few families, is characterized by exercise intolerance, recurrent myoglobinuria, developmental delay, ataxia, and seizures.
OBJECTIVE:
To report a rare manifestation of CoQ(10) deficiency with isolated mitochondrial myopathy without central nervous system involvement.
METHODS:
The patient was evaluated for progressive muscle weakness. Comprehensive clinical evaluation and muscle biopsy were performed for histopathologic analysis and mitochondrial DNA and respiratory chain enzyme studies. The patient began taking 150 mg/d of a CoQ(10) supplement.
RESULTS:
The elevated creatine kinase and lactate levels with abnormal urine organic acid and acylcarnitine profiles in this patient suggested a mitochondrial disorder. Skeletal muscle histochemical evaluation revealed ragged red fibers, and respiratory chain enzyme analyses showed partial reductions in complex I, I + III, and II + III activities with greater than 200% of normal citrate synthase activity. The CoQ(10) concentration in skeletal muscle was 46% of the normal reference mean. The in vitro addition of 50 micromol/L of coenzyme Q(1) to the succinate cytochrome-c reductase assay of the patient's skeletal muscle whole homogenate increased the succinate cytochrome-c reductase activity 8-fold compared with 2.8-fold in the normal control homogenates. Follow-up of the patient in 6 months demonstrated significant clinical improvement with normalization of creatine kinase and lactate levels.
CONCLUSIONS:
The absence of central nervous system involvement and recurrent myoglobinuria expands the clinical phenotype of this treatable mitochondrial disorder. The complete recovery of myopathy with exogenous CoQ(10) supplementation observed in this patient highlights the importance of early identification and treatment of this genetic disorder.
AuthorsSeema R Lalani, Georgirene D Vladutiu, Katie Plunkett, Timothy E Lotze, Adekunle M Adesina, Fernando Scaglia
JournalArchives of neurology (Arch Neurol) Vol. 62 Issue 2 Pg. 317-20 (Feb 2005) ISSN: 0003-9942 [Print] United States
PMID15710863 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Coenzymes
  • DNA, Mitochondrial
  • Ubiquinone
  • Lactic Acid
  • Creatine Kinase
  • coenzyme Q10
Topics
  • Biopsy (methods)
  • Child
  • Coenzymes
  • Creatine Kinase (urine)
  • DNA, Mitochondrial (metabolism)
  • Electron Transport (physiology)
  • Humans
  • Lactic Acid (urine)
  • Male
  • Microscopy, Electron, Transmission (methods)
  • Mitochondria, Muscle (enzymology, pathology, ultrastructure)
  • Mitochondrial Myopathies (diet therapy, enzymology, genetics, physiopathology)
  • Muscle Weakness (drug therapy, enzymology, genetics, physiopathology)
  • Muscle, Skeletal (enzymology, pathology, physiopathology, ultrastructure)
  • Staining and Labeling (methods)
  • Ubiquinone (administration & dosage, analogs & derivatives, deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: